Literature DB >> 5131642

Regression of spontaneous mammary tumors in rats by ergot drugs.

S K Quadri, J Meites.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5131642     DOI： 10.3181/00379727-138-36036

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  5 in total

1.  Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.

Authors:  L Varga; P M Lutterbeck; J S Pryor; R Wenner; H Erb
Journal:  Br Med J       Date:  1972-06-24

2.  Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline.

Authors:  Ludmila Astaf'eva; Ludmila Shishkina; Pavel Kalinin; Boris Kadashev; Galina Melnichenko; Dariia Tserkovnay; Oleg Sharipov
Journal:  Asian J Neurosurg       Date:  2020-05-29

3.  Breast cancer in a male patient with prolactinoma.

Authors:  S Haga; O Watanabe; T Shimizu; T Iida; H Imamura; T Kajiwara; M Fujibayashi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 4.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

5.  Characteristics of 106 spontaneous mammary tumours appearing in Sprague-Dawley female rats.

Authors:  M Okada; J Takeuchi; M Sobue; K Kataoka; Y Inagaki; M Shigemura; T Chiba
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.